QUANTUM BIOPHAR (QNTM)
(Delayed Data from NSDQ)
$3.85 USD
+0.09 (2.39%)
Updated Sep 27, 2024 03:57 PM ET
After-Market: $3.78 -0.07 (-1.82%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
QNTM 3.85 +0.09(2.39%)
Will QNTM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for QNTM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QNTM
QUANTUM BIOPHAR (QNTM) Upgraded to Buy: Here's What You Should Know
QNTM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for QNTM
Quantum Biopharma Provides Corporate Update
Quantum Biopharma regains Nasdaq compliance
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
Quantum Group says Celly Nutrition launches unbuzzed stick packs on Amazon
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update